Introduction {#H1-1-ZOI190581}
============

Malnutrition is a major public health problem, particularly in the multimorbid medical population, affecting more than 30% of hospitalized patients.^[@zoi190581r1],[@zoi190581r2],[@zoi190581r3],[@zoi190581r4]^ It results from the complex interplay of different predisposing factors, including immobilization and advanced age and the associations of illness with protein and energy homeostasis, protein catabolism, hormonal function, and appetite that lead to progressive weight loss and sarcopenia.^[@zoi190581r5],[@zoi190581r6]^

Malnutrition is a major risk factor associated with high mortality and morbidity, functional decline, prolonged hospital stays, and increased health care costs.^[@zoi190581r2],[@zoi190581r7]^ Nutritional support, when provided during the hospital stay, may offset some of these adverse outcomes. For this reason, international societies^[@zoi190581r4],[@zoi190581r8]^ recommend screening patients for malnutrition risk and using nutritional support in patients at nutritional risk or who are malnourished. However, these recommendations have been largely based on physiological rationales. Two meta-analyses of trials investigating the use of nutritional support for medical and mixed medical, surgical, and critically ill inpatients did not find significant associations with outcomes, including mortality and several complications.^[@zoi190581r9],[@zoi190581r10]^ Yet, the quality of the included studies was low, limiting any strong conclusions.

Considering these results, some authors have argued against the routine use of nutritional support in treating medical inpatients at nutritional risk and classified nutritional interventions as "services for which harms are likely to outweigh benefits."^[@zoi190581r11]^ Since the publication of the previously mentioned meta-analyses,^[@zoi190581r9],[@zoi190581r10]^ however, several large, high-quality trials were published that may change the overall conclusions. Therefore, our aim was to perform an updated systematic review and meta-analysis to assess the associations of nutritional support with clinical outcomes in non--critically ill medical inpatients with malnutrition or at nutritional risk, overall and stratified by different subgroups.

Methods {#H1-2-ZOI190581}
=======

The methods used for this updated systematic review and meta-analysis were consistent with an initial analysis,^[@zoi190581r9]^ which followed a prespecified Cochrane protocol^[@zoi190581r12]^ and the Preferred Reporting Items for Systematic Reviews and Meta-analyses ([PRISMA](http://www.equator-network.org/reporting-guidelines/prisma/)) reporting guidelines,^[@zoi190581r13]^ as summarized below.

Data Sources and Searches {#H2-1-ZOI190581}
-------------------------

The literature searches were conducted in the Cochrane Library, MEDLINE, and Embase electronic databases from January 1, 2015, just after the last date reviewed in the prior meta-analysis,^[@zoi190581r9]^ to April 30, 2019. An example of the search strategy used in MEDLINE is provided in the eAppendix in the [Supplement](#note-ZOI190581-1-s){ref-type="supplementary-material"}. In addition, we searched bibliographies of review articles and the ClinicalTrials.gov registry for ongoing or unpublished trials. Authors of ongoing nutritional support studies were also contacted. There were no language restrictions.

Study Selection {#H2-2-ZOI190581}
---------------

We systematically searched the literature to identify randomized and nonrandomized clinical trials (RCTs) that allocated non--critically ill medical inpatients who are malnourished or at nutritional risk (based on body mass index, the presence of a disease associated with malnutrition, or the use of a nutritional assessment or screening tool) to a nutritional support intervention or a control group. Medical inpatients were defined as patients hospitalized in medical wards of acute care institutions (including those of geriatrics, gastroenterology, cardiology, pulmonology, general internal medicine, infectious diseases, nephrology, and oncology). The exclusion criteria were as follows: studies conducted in outpatient care settings, nursing homes, long-term care facilities, or intensive care units and trials focusing on surgical patients, patients with pancreatitis (because of their particular nutritional needs and the management of this condition), and those receiving palliative care.

We included studies with interventions consisting of any type of nutritional support (including dietary advice, changes in the organization of nutritional care, food fortification, extra snacks, oral nutrition supplements, and enteral tube feeding) except parenteral nutrition, independent of the duration of the intervention.

The primary study outcome was all-cause mortality, defined as death from any cause and measured at hospital discharge or at follow-up (up to 6 months after randomization). Secondary end points included nosocomial infections, nonelective readmissions, functional outcome (assessed by the Barthel index score at follow-up), length of hospital stay (LOS), daily energy and protein intake, and body weight change. We also gathered information about adherence to the nutritional intervention and the study protocol. Older studies were defined as those published before 2015^[@zoi190581r14],[@zoi190581r15],[@zoi190581r16],[@zoi190581r17],[@zoi190581r18],[@zoi190581r19],[@zoi190581r20],[@zoi190581r21],[@zoi190581r22],[@zoi190581r23],[@zoi190581r24],[@zoi190581r25],[@zoi190581r26],[@zoi190581r27],[@zoi190581r28],[@zoi190581r29],[@zoi190581r30],[@zoi190581r31],[@zoi190581r32],[@zoi190581r33]^ (included in the original meta-analysis^[@zoi190581r9]^) and newer studies as those published since 2015^[@zoi190581r34],[@zoi190581r35],[@zoi190581r36],[@zoi190581r37],[@zoi190581r38]^ (identified in the updated meta-analysis).

Data Extraction and Quality Assessment {#H2-3-ZOI190581}
--------------------------------------

Two of us (F.G. and A.B.) independently screened abstracts, extracted relevant data from the studies that met the inclusion criteria, and assessed their risk of bias. Disagreements were resolved by consulting one of us (P.S.). Two of us (A.B. and L.B.) assessed the trials in which another 2 of us (N.E.D. and P.S.) were directly involved.^[@zoi190581r36],[@zoi190581r38]^ As recommended by the Cochrane Collaboration, the following criteria were used to assess risk of bias: random sequence generation (selection bias); randomization concealment (selection bias); blinding (performance bias and detection bias), separated for blinding of participants and personnel, and blinding of outcome assessment; incomplete outcome data (attrition bias); selective reporting (reporting bias); and other bias.

Statistical Analysis {#H2-4-ZOI190581}
--------------------

Dichotomous data were reported as odds ratios (ORs) or risk ratios (RRs) with 95% CIs and continuous data as the mean differences with 95% CIs. Data were pooled using a random-effects model.

We identified heterogeneity through visual inspection of the forest plots and also considered the *I*^2^ statistic, which quantifies inconsistency across studies. An *I*^2^ statistic value of 50% or more indicates a considerable level of heterogeneity. We used visual inspection of funnel plots to assess publication bias.

We conducted the following subgroup analyses: stratification by degree of malnutrition (established malnutrition vs risk of malnutrition), by baseline mortality rate in the control group (high mortality \[≥10%\] vs low mortality \[\<10%\]), by adherence to the nutrition protocol (high adherence vs low adherence, as described in the eTable in the [Supplement](#note-ZOI190581-1-s){ref-type="supplementary-material"}), by route of nutritional support (oral vs mixed routes), and by publication year (older \[2014 or earlier\] vs newer \[2015 or later\]).

All of the analyses were conducted with statistical significance set at *P* = .05, and the testing was 2-sided. Most figures were produced using Review Manager, version 5.3 (Cochrane Collaboration).

Results {#H1-3-ZOI190581}
=======

After discarding duplicates, we identified 265 abstracts from the 3 electronic databases and 5 additional records through manual searches and contact with experts. Five new eligible trials including 3067 participants that were published between 2015 and 2019 were identified. Among these 5 trials were 2 large trials including 652 patients^[@zoi190581r36]^ and 2028 patients.^[@zoi190581r38]^ Data from these 5 new trials were extracted and added to the original data file.^[@zoi190581r9]^ The final analysis included a total of 27 trials with 6803 patients (including 5 from the new search and 22 from the previous one) (eFigure 1 in the [Supplement](#note-ZOI190581-1-s){ref-type="supplementary-material"}). [Table 1](#zoi190581t1){ref-type="table"} provides an overview of the characteristics of these included studies.

###### Overview of Included Studies

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source                                                                         Patient Population                                         Country           Total Sample Size   Intervention Group                                                                                                                                                                                                                           Control Group
  ------------------------------------------------------------------------------ ---------------------------------------------------------- ----------------- ------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Bonilla-Palomas et al,^[@zoi190581r34]^ 2016                                   Acute decompensated heart failure                          Spain             120                 Conventional treatment for heart failure combined with an individualized nutritional intervention: diet optimization, specific recommendations, ONS if nutritional goals were not reached, for 6 mo                                          Conventional treatment for heart failure

  Broqvist et al,^[@zoi190581r14]^ 1994                                          Acute decompensated heart failure                          Sweden            21                  Normal hospital food and between meals with 500 mL ONS daily containing 30 g protein and 750 kcal                                                                                                                                            Normal hospital food and 1:10 diluted placebo version of ONS

  Bunout et al,^[@zoi190581r15]^ 1989                                            Alcoholic liver disease                                    Chile             36                  Oral diet including 50 kcal/kg/d, 1.5 g protein/kg/d, casein-based product                                                                                                                                                                   Standard diet

  Cano-Torres et al,^[@zoi190581r35]^ 2017                                       General medical inpatients                                 Mexico            55                  Individualized nutrition plan according to energy and protein (1.0-1.5 g/kg) intake requirements as well as dietary advice based on face-to-face interviews with patients and their caregivers or family members, until hospital discharge   Standard nutritional management

  Deutz et al,^[@zoi190581r36]^ 2016                                             General medical inpatients (≥65 y of age)                  United States     652                 2 Bottles ONS daily providing 700 kcal/d, 40 g protein/d, 3 g calcium- beta-hydroxybeta-methylbutyrate, 160 IU vitamin D, and other essential micronutrients, for 90 d                                                                       2 Bottles placebo ONS providing 96 kcal and 20 mg vitamin C

  Feldblum et al,^[@zoi190581r33]^ 2011                                          General medical inpatients (≥65 y of age)                  Israel            259                 Individual nutritional treatment, 237 mL containing 12.6 g fat, 13 g protein, and 47.3 g carbohydrates (total, 360 kcal), additional food fortification                                                                                      Routine care on request

  Gariballa et al,^[@zoi190581r16]^ 2006                                         General medical inpatients (≥65 y of age)                  United Kingdom    445                 2 Bottles (200 mL each) ONS daily, 995 kcal/d plus vitamins                                                                                                                                                                                  Oral placebo (60 kcal)

  Gazzotti et al,^[@zoi190581r17]^ 2003                                          General medical inpatients (≥75 y of age)                  Belgium           80                  Standard hospital food and 1 Clinutren soup, 500 kcal/d, 21 g protein/d                                                                                                                                                                      Standard hospital food, no supplements

  Hickson et al,^[@zoi190581r18]^ 2004                                           General medical inpatients (≥65 y of age)                  United Kingdom    592                 Nutritional care from health care assistants, snacks and drinks                                                                                                                                                                              Usual care

  Hogarth et al,^[@zoi190581r19]^ 1996                                           General geriatric inpatients                               United Kingdom    25                  Intervention 1: daily 750 mL oral glucose supplement (540 kcal) and capsules containing vitamins A (8000 U), B~1~ (15 mg), B~2~ (15 mg), B~3~ (50 mg), B~6~ (10 mg), and C (500 mg), for 1 mo\                                               Control 1: Nutrasweet glucose drink and capsules containing vitamins A (8000 U), B~1~ (15 mg), B~2~ (15 mg), B~3~ (50 mg), B~6~ (10 mg), and C (500 mg), for 1 mo\
                                                                                                                                                                                  Intervention 2: daily 750 mL oral glucose supplement (540 kcal) and placebo capsules for 1 mo                                                                                                                                                Control 2: Nutrasweet glucose drink and placebo capsules for 1 mo

  Holyday et al,^[@zoi190581r20]^ 2012                                           General geriatric inpatients                               Australia         143                 Individual modification of hospital meals (fortification), nutrition supplements                                                                                                                                                             Individual modification only on request

  Huynh et al,^[@zoi190581r37]^ 2015                                             General medical inpatients                                 India             212                 Dietary counseling +2 bottles ONS daily providing 432 kcal/d and 16 g protein/d plus micronutrients, for 12 weeks                                                                                                                            Dietary counseling alone

  McEvoy and James,^[@zoi190581r21]^ 1982                                        General medical inpatients                                 United Kingdom    54                  2 Sachets oral "Build-Up" daily, 36.4 g protein and 644 kcal                                                                                                                                                                                 Normal hospital diet

  McWhirter and Pennington,^[@zoi190581r22]^ 1996                                General medical inpatients                                 United Kingdom    86                  \(a\) ONS containing 566 kcal/d, 23.9 g protein/d\                                                                                                                                                                                           Standard hospital diet
                                                                                                                                                                                  (b) Nocturnal tube feeding (nasogastric tube), additional intake of 84 kcal/d and 29.5 g protein/d                                                                                                                                           

  Munk et al,^[@zoi190581r23]^ 2014                                              Inpatients from oncology, orthopedics, and urology wards   Denmark           81                  Protein-enriched small dishes supplementary to standard food service, ONS or snacks                                                                                                                                                          Standard hospital diet

  Neelemaat et al,^[@zoi190581r24]^ 2012                                         General medical inpatients (≥60 y of age)                  The Netherlands   210                 Energy- and protein-enriched diet, 2 additional servings of ONS, 2520 kJ/d (to convert to kcal, divide by 4.186), 24 g protein/d, orally 400 U Vitamin D~3~ and 500 mg calcium/d, telephone counseling                                       Usual care

  Ollenschläger et al,^[@zoi190581r25]^ 1992                                     Patients with induction treatment for leukemia             Germany           29                  Menus of free choice, nutritional education, daily visits by the dietician, and record of food intake                                                                                                                                        Menus of free choice, no nutritional education

  Potter et al,^[@zoi190581r26]^ 2001 and Roberts et al,^[@zoi190581r27]^ 2003   General geriatric inpatients                               United Kingdom    381                 120 mL oral sip-feed supplement 3/d, 540 kcal/d, 22.5 g protein                                                                                                                                                                              Normal hospital food

  Rüfenacht et al,^[@zoi190581r28]^ 2010                                         General medical inpatients                                 Switzerland       36                  Individual nutritional plan with food enrichment, energy- and/or protein-rich snacks, beverages and energy-dense ONS                                                                                                                         2 U ONS providing 200 mL each with 300 kcal and 12 g protein

  Ryan et al,^[@zoi190581r29]^ 2004                                              General medical inpatients (≥65 y of age)                  France            16                  Oral supplement (1050 kJ \[to convert to kcal, divide by 4.186\], 250 mL)                                                                                                                                                                    Standard hospital breakfast

  Saudny-Unterberger et al,^[@zoi190581r30]^ 1997                                Inpatients with COPD exacerbation (40-85 y of age)         Canada            33                  ONS, 39 kcal/kg/d                                                                                                                                                                                                                            Standard food, 29 kcal/kg/d

  Schuetz et al,^[@zoi190581r38]^ 2019                                           General medical inpatients                                 Switzerland       2028                A systematic nutritional assessment by a dietitian was done to define nutritional targets, followed by individualized early nutritional support based on a previously published consensus algorithm and current nutritional guidelines       Standard nutritional management

  Somanchi et al,^[@zoi190581r39]^ 2011                                          General medical inpatients                                 United States     400                 Nutritional screening of all patients, clinical nutritional plan initiated by the nurse manager                                                                                                                                              Usual hospital screening and nutritional counseling on demand

  Starke et al,^[@zoi190581r40]^ 2011                                            General medical inpatients                                 Switzerland       132                 Individual nutritional care (food supply, fortification of meals with maltodextrins, rapeseed oil, cream and/or protein, powder, in-between snacks, and ONS); protein intake 1.0 g/kg body weight                                            Standard nutritional care, including prescription of ONS upon discretion of physician

  Vermeeren et al,^[@zoi190581r31]^ 2004                                         Inpatients with COPD exacerbation                          The Netherlands   56                  Liquid oral supplement 3x 125 mL, 2.38 MJ/d (to convert to kcal, divide by 0.0041858), 20 energy % protein, 20 energy % fat, and 60 energy % carbohydrate, standardized dietetic consultation                                                Free choice of normal hospital food and placebo 3 × 125 mL, 0 MJ/d

  Vlaming et al,^[@zoi190581r32]^ 2001                                           General medical, surgical, or orthopedic inpatients        United Kingdom    549                 Normal hospital food plus 400 mL oral sip-feed supplement, 600 kcal/d, 25.0 g protein/d, 80.8 g carbohydrates/d, 19.6 g fat/d, multivitamins                                                                                                 Normal hospital food plus 400 mL placebo, 100 kcal/d, 25 g carbohydrates/d plus multivitamins

  Volkert et al,^[@zoi190581r41]^ 1996                                           General geriatric inpatients                               Germany           72                  Normal hospital food and 400 mL/d (2100 kJ \[to convert to kcal divide by 4.186\]) liquid supplement, 200 mL/d (1050 kJ) for the following 6 mo at home                                                                                      Normal hospital food, usual care without supplements
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: COPD, chronic obstructive pulmonary disease; ONS, oral nutrition supplements.

Assessment of risk of bias, which was performed as recommended by the Cochrane Collaboration (risk of bias graph in eFigure 2 in the [Supplement](#note-ZOI190581-1-s){ref-type="supplementary-material"}), revealed that of the 27 studies, 17 had a low risk of random sequence generation and randomization concealment bias, 15 had a low risk of attrition bias for objective outcomes, and 19 had a low risk of reporting bias. Approximately 70% of the studies had high risk of performance bias for objective outcomes because blinding of participants and personnel was not undertaken. There was a large proportion of unclear risk of bias related to studies not reporting subjective outcomes. Other biases were not detected in most trials. Overall, risk of bias was less pronounced in the present study compared with the initial report,^[@zoi190581r9]^ with newer trials showing better methodological quality. Funnel plots revealed no evidence of publication bias.

Primary Outcome {#H2-5-ZOI190581}
---------------

The analyses of the outcomes in the overall population and in subgroups are provided in [Table 2](#zoi190581t2){ref-type="table"}. A total of 17 studies^[@zoi190581r14],[@zoi190581r15],[@zoi190581r16],[@zoi190581r18],[@zoi190581r19],[@zoi190581r20],[@zoi190581r23],[@zoi190581r24],[@zoi190581r26],[@zoi190581r30],[@zoi190581r32],[@zoi190581r34],[@zoi190581r35],[@zoi190581r36],[@zoi190581r38],[@zoi190581r40],[@zoi190581r41]^ (13 older and 4 newer) reported data on mortality, the primary outcome. The association of the intervention with mortality risk for each trial, as well as the overall association stratified by newer vs older trials is shown in [Figure 1](#zoi190581f1){ref-type="fig"}. The mortality rate was 8.3% (230 of 2758) among the intervention group patients compared with 11.0% (307 of 2787) among the control group patients (OR, 0.73; 95% CI, 0.56-0.97, *P* = .03). There was a low level of heterogeneity among trials (*I*^2^ = 35%, *P* = .08) ([Table 2](#zoi190581t2){ref-type="table"}). This significant reduction in mortality associated with the nutritional support was different from the nonsignificant association observed in the original meta-analysis (OR, 0.96; 95% CI, 0.72-1.27).^[@zoi190581r9]^

###### Outcome Analyses: Overall Population and Subgroups

  Population/Variable                                               Mortality, OR (95% CI)   Infections, OR (95% CI)   Nonelective Readmissions, Risk Ratio (95% CI)   Mean Difference (95% CI)                                                                     
  ----------------------------------------------------------------- ------------------------ ------------------------- ----------------------------------------------- -------------------------- ------------------------ ------------------ --------------------- ------------------------
  Overall population                                                                                                                                                                                                                                                
  Intervention, events/total (%) or mean, No.                       230/2758 (8.3)           88/1817 (4.8)             280/1903 (14.7)                                 17.3                       11.5                     1618               59                    0.63
  Control, events/total (%) or mean, No.                            307/2787 (11.0)          102/1825 (5.6)            339/1880 (18.0)                                 16.9                       12.0                     1331               48                    −0.19
  Overall OR mean difference (95% CI)                               0.73 (0.56 to 0.97)      0.86 (0.64 to 1.16)       0.76 (0.60 to 0.96)                             0.32 (−0.51 to 1.15)       −0.24 (−0.58 to 0.09)    365 (272 to 458)   17.7 (12.1 to 23.3)   0.73 (0.32 to 1.13)
  *I*^2^ Test for overall effect, %                                 35                       0                         48                                              77                         0                        84                 88                    100
  Subgroup analysis stratified by degree of malnutrition                                                                                                                                                                                                            
  Established malnutrition                                          0.52 (0.34 to 0.80)      NA                        0.36 (0.20 to 0.64)                             4.00 (1.69 to 6.31)        −2.08 (−4.19 to 0.02)    304 (218 to 389)   16.1 (5.1 to 27.1)    0.96 (0.42 to 1.50)
  At nutritional risk                                               0.85 (0.62 to 1.18)      0.86 (0.64 to 1.15)       0.86 (0.74 to 1.00)                             0.02 (−0.54 to 0.59)       −0.17 (−0.51 to 0.17)    394 (262 to 526)   16.3 (9.8 to 22.9)    0.86 (0.79 to 0.93)
  *I*^2^ Test for subgroup difference, %                            69                       NA                        88                                              91                         68                       21                 0                     0
  Subgroup analysis stratified by mortality rate in control group                                                                                                                                                                                                   
  High mortality (≥10%)                                             0.61 (0.43 to 0.87)      0.77 (0.17 to 3.46)       0.28 (0.12 to 0.65)                             0.85 (−1.47 to 3.16)       −1.32 (−2.52 to −0.12)   231 (81 to 280)    16.0 (2.9 to 29.2)    0.14 (−0.61 to 0.88)
  Low mortality (\<10%)                                             0.91 (0.59 to 1.40)      0.86 (0.64 to 1.17)       0.86 (0.72 to 1.02)                             0.14 (−0.70 to 0.98)       −0.12 (−0.49 to 0.24)    428 (316 to 540)   16.8 (9.9 to 23.6)    0.86 (0.79 to 0.93)
  *I*^2^ Test for subgroup difference, %                            49                       0                         85                                              0                          71                       77                 0                     73
  Stratification by adherence to nutrition protocol                                                                                                                                                                                                                 
  High adherence                                                    0.67 (0.54 to 0.84)      0.89 (0.62 to 1.26)       0.91 (0.76 to 1.10)                             0.56 (0.07 to 1.05)        −0.17 (−0.52 to 0.19)    402 (313 to 491    19.6 (12.9 to 26.3)   0.87 (0.81 to 0.93)
  Low adherence                                                     0.88 (0.44 to 1.76)      0.79 (0.45 to 1.38)       0.58 (0.36 to 0.96)                             0.33 (−0.88 to 1.55)       −0.82 (−1.80 to 0.16)    107 (24 to 191)    8.3 (−3.2 to 19.8)    −0.20 (−0.23 to −0.17)
  *I*^2^ Test for subgroup difference, %                            0                        0                         64                                              0                          34                       96                 64                    100
  Stratification by route of nutritional support                                                                                                                                                                                                                    
  Oral routes                                                       0.74 (0.58 to 0.93)      0.75 (0.50 to 1.11)       0.74 (0.56 to 0.99)                             0.33 (−0.88 to 1.55)       −0.26 (−0.67 to 0.15)    367 (247 to 487)   16.2 (9.5 to 22.8)    0.761 (0.27 to 1.14)
  Mixed routes                                                      0.71 (0.52 to 0.97)      1.02 (0.65 to 1.61)       0.73 (0.35 to 1.53)                             0.56 (0.07 to 1.05)        −0.98 (−3.32 to 1.36)    417 (108 to 727)   28.8 (−9.0 to 66.6)   0.90 (0.89 to 0.91)
  *I*^2^ Test for subgroup difference, %                            0                        6                         0                                               0                          0                        0                  0                     0
  Stratification by publication year                                                                                                                                                                                                                                
  Older (2014 or earlier)                                           0.94 (0.72 to 1.22)      0.75 (0.50 to 1.11)       0.71 (0.57 to 0.87)                             0.33 (−0.88 to 1.55)       −0.42 (−1.09 to 0.24)    396 (272 to 520)   18.5 (11.2 to 25.9)   0.66 (0.17 to 1.15)
  Newer (2015 or later)                                             0.47 (0.28 to 0.79)      1.02 (0.65 to 1.61)       0.78 (0.50 to 1.22)                             0.56 (0.07 to 1.05)        −0.27 (−0.87 to 0.33)    286 (239 to 333)   10.0 (8.1 to 11.9)    0.86 (0.78 to 0.95)
  *I*^2^ Test for subgroup difference, %                            81                       6                         0                                               0                          0                        62                 79                    0

Abbreviations: NA, not applicable; OR, odds ratio.

![Forest Plot Comparing Nutritional Intervention vs Control for Mortality, Stratified by Publication Year\
A Mantel-Haenszel random-effects model was used. Squares indicate mean values, with the size of squares reflecting the weight and the lines indicating 95% CIs. Diamonds indicate pooled estimates, with horizontal points of the diamonds indicating 95% CIs. OR indicates odds ratio.](jamanetwopen-2-e1915138-g001){#zoi190581f1}

Secondary Outcomes {#H2-6-ZOI190581}
------------------

Rates of nonelective hospital readmissions were reported in 9 studies^[@zoi190581r16],[@zoi190581r17],[@zoi190581r20],[@zoi190581r31],[@zoi190581r34],[@zoi190581r36],[@zoi190581r38],[@zoi190581r39],[@zoi190581r40]^ ([Table 2](#zoi190581t2){ref-type="table"} and [Figure 2](#zoi190581f2){ref-type="fig"}). Compared with the control group, nutritional support interventions were associated with a significant reduction of nonelective hospital readmissions (14.7% \[280 of 1903\] in the intervention vs 18.0% \[339 of 1880\] in the control group; RR, 0.76; 95% CI, 0.60-0.96; *P* = .02), although there was heterogeneity among trials (*I*^2^ = 48%, *P* = .05). There was no statistically significant difference between the older and newer studies. The original meta-analysis^[@zoi190581r9]^ had also reported an association between nutritional support and reduced nonelective hospital readmissions (RR, 0.71; 95% CI, 0.57-0.87).

![Forest Plot Comparing Nutritional Intervention vs Control for Nonelective Hospital Readmissions, Stratified by Publication Year\
A Mantel-Haenszel random-effects model was used. Squares indicate mean values, with the size of squares reflecting the weight and the lines indicating 95% CIs. Diamonds indicate pooled estimates, with horizontal points of the diamonds indicating 95% CIs. RR indicates risk ratio.\
^a^Calculated and approximated from readmission frequency.\
^b^Calculated and approximated from readmission rate.](jamanetwopen-2-e1915138-g002){#zoi190581f2}

Compared with the control group, the intervention group patients had no differences in rates for infections (4.8% \[88 of 1817\] vs 5.6% \[102 of 1825\]; OR, 0.86; 95% CI, 0.64-1.16), functional outcome at follow-up (17.3 vs 16.9 points; mean difference in Barthel index score, 0.32 points; 95% CI, −0.51 to 1.15), or LOS (11.5 days vs 12.0 days; mean difference, −0.24 days; 95% CI, −0.58 to 0.09) ([Table 2](#zoi190581t2){ref-type="table"} and eFigures 3, 4, and 5 in the [Supplement](#note-ZOI190581-1-s){ref-type="supplementary-material"}).

Regarding nutritional outcomes ([Table 2](#zoi190581t2){ref-type="table"} and eFigures 6, 7, and 8 in the [Supplement](#note-ZOI190581-1-s){ref-type="supplementary-material"}), nutritional support interventions were associated with a significantly higher energy intake (1618 kcal in the intervention group vs 1331 kcal in the control group; mean difference, 365 kcal; 95% CI, 272-458 kcal) and protein intake (59 g in the intervention group vs 48 g in the control group; mean difference, 17.7 g; 95% CI, 12.1-23.3 g). In addition, there was a significant increase in body weight (0.63 kg in the intervention group vs −0.19 kg in the control group; mean difference, 0.73 kg; 95% CI, 0.32-1.13 kg). Heterogeneity among trials was high (*I*^2^ = 84% \[energy intake\], *I*^2^ = 88% \[protein intake\], and *I*^2^ = 100% \[weight change\]).

Sensitivity Analyses {#H2-7-ZOI190581}
--------------------

Trials were stratified according to the degree of malnutrition, baseline mortality rate in the control group, adherence to the nutrition protocol, route of nutritional support, and publication year (before or after 2015) ([Table 2](#zoi190581t2){ref-type="table"}).

The sensitivity analysis suggested a more pronounced reduction in the risk of mortality in recent trials (2015 or later) (OR, 0.47; 95% CI, 0.28-0.79) compared with that in older studies (OR, 0.94; 95% CI, 0.72-1.22), in patients with established malnutrition (OR, 0.52; 95% CI, 0.34-0.80) compared with that in patients at nutritional risk (OR, 0.85; 95% CI, 0.62-1.18), and in trials with high protocol adherence (OR, 0.67; 95% CI, 0.54-0.84) compared with that in trials with low protocol adherence (OR, 0.88; 95% CI, 0.44-1.76).

The results suggest larger benefits associated with nutritional support for the subgroup of patients with established malnutrition compared with that for the subgroup of patients at nutritional risk, particularly for functional outcome and nonelective hospital readmissions (and a beneficial association between nutritional support and mortality and LOS). Among the individuals with a higher mortality rate (≥10%) vs those with a lower mortality rate (\<10%), the associations of the intervention were stronger. However, this effect was only significant for nonelective readmissions and energy intake.

There was no evidence of other associations in subgroup analyses based on protocol adherence or route of nutritional support except for energy intake and weight change, which was increased in the studies with high adherence to the nutrition protocol (energy intake \[402 kcal\]; weight change \[0.87 kg\]) compared with the studies with lower adherence (energy intake \[107 kcal\]; weight change \[−0.20 kg\]). Associations between nutritional support and mortality reduction and weight gain were more pronounced in newer studies compared with the older trials.

An additional sensitivity analysis was performed to better understand whether associations of nutritional support would be similar if the largest trial (EFFORT \[Effect of Early Nutritional Support on Frailty, Functional Outcomes, and Recovery of Malnourished Medical Inpatients Trial\]^[@zoi190581r38]^) was excluded ([Table 3](#zoi190581t3){ref-type="table"}). When excluding EFFORT trial data from the analysis, associations of nutritional support with mortality (OR, 0.73; 95% CI, 0.52-1.03), as well as nonelective hospital readmissions (RR, 0.71; 95% CI, 0.54-0.94), were similar.

###### Outcome Analyses With and Without EFFORT^[@zoi190581r38]^

  Population/Variable                           Mortality, OR (95% CI)   Infections, OR (95% CI)   Nonelective Readmissions, Risk Ratio (95% CI)   Mean Difference (95% CI)                                                                    
  --------------------------------------------- ------------------------ ------------------------- ----------------------------------------------- -------------------------- ----------------------- ------------------ --------------------- ---------------------
  Overall population                                                                                                                                                                                                                           
  Intervention, events/total (%) or mean, No.   230/2758 (8.3)           88/1817 (4.8)             280/1903 (14.7)                                 17.3                       11.5                    1618               59                    0.63
  Control, events/total (%) or mean, No.        307/2787 (11.0)          102/1825 (5.6)            339/1880 (18.0)                                 16.9                       12.0                    1331               48                    −0.19
  Overall estimate                              0.73 (0.56 to 0.97)      0.86 (0.64 to 1.16)       0.76 (0.60 to 0.96)                             0.32 (−0.51 to 1.15)       −0.24 (−0.58 to 0.09)   365 (272 to 458)   17.7 (12.1 to 23.3)   0.73 (0.32 to 1.13)
  *I*^2^ Test for overall effect, %             35                       0                         48                                              77                         0                       84                 88                    100
  Overall population without EFFORT                                                                                                                                                                                                            
  Intervention, events/total (%) or mean, No.   157/1743 (9.0)           48/802 (5.9)              191/888 (21.5)                                  15.5                       12.8                    1950               73                    0.37
  Control, events/total (%) or mean, No.        207/1774 (11.7)          63/812 (7.8)              248/867 (28.6)                                  14.8                       14.0                    1543               54                    −0.21
  Overall estimate                              0.73 (0.52 to 1.03)      0.75 (0.50 to 1.11)       0.71 (0.54 to 0.94)                             0.33 (−0.88 to 1.55)       −0.38 (−0.85 to 0.10)   382 (266 to 498)   18.5 (11.2 to 26.9)   0.71 (0.27 to 1.14)
  *I*^2^ Test for overall effect, %             39                       0                         47                                              78                         5                       84                 89                    99

Abbreviations: EFFORT, Effect of Early Nutritional Support on Frailty, Functional Outcomes, and Recovery of Malnourished Medical Inpatients Trial; OR, odds ratio.

Discussion {#H1-4-ZOI190581}
==========

The findings of this updated systematic review and meta-analysis of RCTs investigating the association of nutritional support interventions with outcomes in medical inpatients who are malnourished or at nutritional risk were 3-fold. First, compared with the original meta-analysis^[@zoi190581r9]^ that included trials published before April 2014 (9 trials), the 5 new trials were a higher quality, had lower bias, and collectively nearly doubled the total patient population studied in this updated meta-analysis (3736 patients from the original study plus 3067 patients from the 5 new studies). Newer trials also differed with regard to the nutritional interventions used, with a higher quality of protein^[@zoi190581r13]^ and a more individualized, patient-specific approach. Second, our analysis suggests that nutritional support compared with no support was statistically significantly associated with increased protein and energy intake during the hospital stay, with an increased body weight. Third, our analysis found that nutritional support was associated with a statistically significant reduction in mortality and nonelective hospital readmissions and thus had favorable associations with clinical outcomes beyond the known associations with metabolic parameters.

There are important differences in the results between the original meta-analysis^[@zoi190581r9]^ and the present updated analysis, particularly with regard to mortality. In the original analysis, the mortality difference was 0.5% in favor of nutritional support,^[@zoi190581r9]^ whereas the absolute mortality benefit increased to 2.8% in the present updated analysis, corresponding to a number needed to treat of 36 to prevent 1 death. The inclusion of 2 recent, large, and high-quality RCTs---namely EFFORT^[@zoi190581r38]^ and NOURISH (Nutrition Effect on Unplanned Readmissions and Survival in Hospitalized Patients)^[@zoi190581r36]^ that reported lower mortality associated with nutritional support---may have contributed to this shift in results, although overall heterogeneity regarding the mortality outcome was only low to moderate. This finding suggests that the decreased risk of mortality may have been masked in older studies owing to small sample sizes (eg, 22 patients^[@zoi190581r14]^), lower study quality, and quality of nutritional support used in trials.^[@zoi190581r9]^ Overall, the decreased risk of mortality associated with nutritional support found in the present analysis suggests that malnutrition is a modifiable risk factor for mortality, with nutritional support being an effective treatment option.

These findings differ from those of other recent reviews of nutritional support. A recent Cochrane review^[@zoi190581r10]^ did not find a positive association between nutritional support and outcomes in hospitalized adults at nutritional risk. However, this study included a larger variety of patients, including intensive care unit and surgical patients, who may have specific nutritional and metabolic needs. It should be noted that patients treated in intensive care units tend to be highly catabolic, and it is likely that nutritional support would not alter this process. On the other hand, nutritional support in non--critically ill medical patients who are malnourished may result in increased protein synthesis and increased lean body mass. The Cochrane review^[@zoi190581r10]^ also included a wider range of interventions, including parenteral nutrition, which may be associated with a higher risk for adverse outcomes. Furthermore, the literature searches were conducted in February 2016, which excludes 2 recent, large, nutritional support RCTs of medical inpatients at nutritional risk (the EFFORT trial,^[@zoi190581r38]^ published in 2018 with 2028 patients; and the NOURISH trial,^[@zoi190581r36]^ published in 2016 with 652 patients). Inclusion of these trials may also alter the overall interpretation of this present study.

One could postulate that nutritional support would have limited the loss of lean body mass, thereby improving muscle strength and functional outcomes, but this finding was not observed in the present study. However, only 5 studies^[@zoi190581r16],[@zoi190581r18],[@zoi190581r19],[@zoi190581r38],[@zoi190581r41]^ assessed functional outcomes, defined by the Barthel index score at follow-up (eFigure 4 in the [Supplement](#note-ZOI190581-1-s){ref-type="supplementary-material"}). The absence of any association between nutritional support and improved functional outcomes may be attributable to the methods used in the few studies that assessed this outcome and the relatively short duration of nutritional support (or time for the assessment of functional status).

Of importance, in the present analysis, nutritional support was associated with more benefits in the subgroup of patients with established malnutrition vs than in the patients at nutritional risk, particularly for hospital readmissions, functional outcomes, LOS, and mortality, for which the differences between groups were statistically significant or more pronounced. This finding highlights the importance of using validated methods to assess patients' nutritional status to identify those who are more likely to benefit from nutritional support. A team approach including nurses, dieticians, and physicians may provide a solution to the problem of identifying and appropriately addressing malnutrition in the hospital setting.

In the context of increasing health care costs, the significant reduction in hospital readmissions observed on the overall analysis and the reduction in LOS shown in the subgroup of patients with established malnutrition may be particularly relevant for policy makers. If these findings are borne out in subsequent trials, given that approximately 30% of general medical inpatients meet the criteria for malnutrition,^[@zoi190581r2]^ patient-specific nutritional interventions may result in substantial cost and hospital utilization reductions in addition to the mortality benefits (eg, in an analysis of inpatient use of oral nutritional supplements in more than 1 million participants^[@zoi190581r42]^). Future studies should focus on the cost-effectiveness of providing nutritional support interventions for medically ill patients. The evaluation of other patient-centered outcomes, such as quality of life, should also be explored in more detail.

Limitations {#H2-8-ZOI190581}
-----------

This study has limitations. Several of the included studies had a high or unknown risk of bias, small sample sizes, and short study duration (ie, limited to the hospital stay). Malnutrition starts in the community (the patient is identified as being malnourished on admission to the hospital) and does not end at the hospital discharge; therefore, the causes of malnutrition in the community need to be explored, and nutritional support should be continued after hospital discharge. In addition, heterogeneity was observed with regard to the types of interventions and the control groups. Some trials were placebo-controlled efficacy trials focusing on the effect of specific products, whereas others were effectiveness trials comparing complex interventions with routine care, which may vary across health care settings.

Conclusions {#H1-5-ZOI190581}
===========

This updated systematic review and meta-analysis found that use of nutritional support interventions was associated with clinically significant improvements of important clinical outcomes in the medical inpatient population, in whom malnutrition is highly prevalent.^[@zoi190581r43]^ This analysis supports the current practice guidelines issued by the European Society for Clinical Nutrition and Metabolism (ESPEN)^[@zoi190581r4]^ and the American Society for Parenteral and Enteral Nutrition (ASPEN),^[@zoi190581r8]^ advocating a proactive, screening-based approach for initiating nutritional support during the hospital stay of medical inpatients who are malnourished or at nutritional risk.
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